View Older Stories View More Recent Stories
-
Natera, Inc., Non-Invasive Genetic Testing Leader, Secures $55 Million in Private Financing
-
Form SC 13G/A ACADIA PHARMACEUTICALS Filed by: RA CAPITAL MANAGEMENT, LLC
-
Aurinia Reports Fourth Quarter and Full Year 2014 Financial Results and Highlights Initiation of Its Open Label Clinical Study to Investigate the Impact of Voclosporin on Lupus Nephritis Biomarkers
-
Form SC 13G Aurinia Pharmaceuticals Filed by: RA CAPITAL MANAGEMENT, LLC
-
Aeglea Biotherapeutics Raises $44 Million in Series B Financing
-
Allergen Research Corporation Completes $80 Million Series B Financing to Advance Drug Development Portfolio for Food Allergy
-
Collegium Pharmaceutical Raises $50 Million Financing to Support Commercial Development of Its Lead Abuse-Deterrent Product Candidate
-
Form SC 13G/A SANGAMO BIOSCIENCES INC Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A Ocera Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A NOVAVAX INC Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A Prothena Corp plc Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A DERMA SCIENCES, INC. Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A BIOCRYST PHARMACEUTICALS Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A TREVENA INC Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A ACADIA PHARMACEUTICALS Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A ARROWHEAD RESEARCH CORP Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A SUNESIS PHARMACEUTICALS Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A ENZO BIOCHEM INC Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A DYNAVAX TECHNOLOGIES Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A WaferGen Bio-systems, Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A VICAL INC Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A ACHILLION PHARMACEUTICAL Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A SANGAMO BIOSCIENCES INC Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A TENGION INC Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A Versartis, Inc. Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A SCYNEXIS INC Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A Regulus Therapeutics Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A REPROS THERAPEUTICS INC. Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A pSivida Corp. Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A TG THERAPEUTICS, INC. Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A TENAX THERAPEUTICS, INC. Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A SANUWAVE Health, Inc. Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A TherapeuticsMD, Inc. Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A AmpliPhi Biosciences Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A DYAX CORP Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A ENANTA PHARMACEUTICALS Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A Mirati Therapeutics, Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A Furiex Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A PROTEON THERAPEUTICS Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form 13F-HR RA CAPITAL MANAGEMENT, For: Dec 31
-
Form SC 13G AGILE THERAPEUTICS INC Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G TEKMIRA PHARMACEUTICALS Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A ACHILLION PHARMACEUTICAL Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13D/A ACHILLION PHARMACEUTICAL Filed by: RA CAPITAL MANAGEMENT, LLC
-
Agile Therapeutics (AGRX) Announces $20M Private Placement; Updates Phase 3 SECURE Study
-
Form SC 13G TREVENA INC Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form 13F-HR RA CAPITAL MANAGEMENT, For: Sep 30
-
Form SC 13G Regulus Therapeutics Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G PROTEON THERAPEUTICS Filed by: RA CAPITAL MANAGEMENT, LLC
-
RA Capital Management Shows New 8.3% Stake in TG Therapeutics (TGTX)

